Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study

Publication date: Available online 3 August 2020Source: The Lancet HaematologyAuthor(s): Jean-Marie Michot, Reda Bouabdallah, Umberto Vitolo, Jeanette K Doorduijn, Gilles Salles, Annalisa Chiappella, Pier Luigi Zinzani, Fontanet Bijou, Marie José Kersten, Rafael Sarmiento, Silvia Mosulen, Cristina Mendez, Shailaja Uttamsingh, Michael Pourdehnad, Kristen Hege, Tianlei Chen, Christian Klein, Patrick R Hagner, Zariana Nikolova, Vincent Ribrag
Source: The Lancet Haematology - Category: Hematology Source Type: research